National survey of pharmacists about coronary heart disease, hypercholesterolemia, nonprescription statin therapy, and pharmacists' services

Journal of the American Pharmacists Association

Volumn 44, Issue 5, 2004, Pages 562-568

  McKenney, James M ^a   Chris Bradberry, J ^b   Talbert, Robert L ^c   Cahill, Edward ^d   Virgil Brown, W ^e  

^a National Clinical Research Inc   (United States)

^b CREIGHTON UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d (EC)   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hypercholesterolemia; Lipids; Nonprescription medications; Pharmaceutical care, pharmacists' opinions; Self care; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; CORONARY ARTERY DISEASE; COUNSELING; CROSS-SECTIONAL STUDY; HEALTH PERSONNEL ATTITUDE; HUMAN; HYPERCHOLESTEROLEMIA; PATIENT EDUCATION; PHARMACY; PRESCRIPTION; QUESTIONNAIRE; UNITED STATES;

ATTITUDE OF HEALTH PERSONNEL; COMMUNITY PHARMACY SERVICES; CORONARY DISEASE; COUNSELING; CROSS-SECTIONAL STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; PATIENT EDUCATION; PRESCRIPTIONS, NON-DRUG; QUESTIONNAIRES; UNITED STATES;

EID: 85047688410     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/1544-3191.44.5.562.McKenney     Document Type: Article

References (9)

1. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease. A meta-analysis of randomized controlled trials. JAMA. 1999;282:2340-6.
2. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
3. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495-504.
4. Report of the National Cholesterol Education Program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. The Expert Panel. Arch Intern Med. 1988;148:36-69.
5. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-421.
6. Ford ES, Mokdad AH, Giles WH, Mensah GA. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation. 2003;107:2185-9.
7. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in Project ImPACT: Hyperlipidemia. J Am Pharm Assoc. 2000;40:157-65.
8. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management. The study of cardiovascular risk intervention by pharmacists (SCRIP). Arch Intern Med. 2002;162:1149-55.
9. Pasternak RC, McKenney JM, Brown WV, et al. Understanding physician and consumer attitudes about cholesterol management: results from the National Lipid Association (NLA) surveys. Am J Cardiol. In press.